Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Veracyte

Explore full profile

Diagnostics for cancer

San Francisco, United StatesFounded 2008Biotech & Life Sciences
Valuation $4.38B Market cap · Jul/2026
Revenue $592M Latest reported FY
EBITDA $159M Latest reported FY

At a glance

Status
Listed
Founded
2008
Headquarters
San Francisco, United States
Listing
IPO 2013
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom
News Veracyte buys Convergent Genomics to add urine-based bladder cancer test Sep 14, 2026 News Man Group takes new $1.31M stake in Veracyte as revenue climbs 15.5% Sep 3, 2026

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later6 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 731 incl. 14 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 7 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 7 startups shown

Former Veracyte employees who went on to found companies, sorted by Dealroom signal score.

PinkDxEst. 2022
Bonnie AndersonUnited States
Signal score89
Pr3ventEst. 2018
Jochen KummUnited States
Signal score70
AqtualEst. 2018
Diana AbduevaUnited States
Signal score66
InflammatixEst. 2016
Jonathan RomanowskyUnited States
Signal score65
Menlo MicroEst. 2016
RSRisa StackUnited States
Signal score65
2 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
13 countries with
team presence
🇺🇸 United States77.5%
🇫🇷 France15.3%
🇮🇱 Israel2.6%
🇪🇸 Spain1%
🇩🇪 Germany0.8%
Top 5 of 13 shown
Web traffic by country
53K monthly visits
across markets
🇺🇸 United States72.6%
🇨🇦 Canada9.2%
🇬🇧 United Kingdom8.3%
🇮🇳 India4%
🇫🇷 France1.3%
Top 5 markets shown

Patents

Estimated portfolio value
$38M

34 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Veracyte was the backer or acquirer, 2014–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Veracyte's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Veracyte's portfolio, mapped.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Veracyte on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Veracyte on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles